Infinity Pharmaceuticals : Encouraging Updated Data from Phase 2 MARIO-3 TNBC Trial Presented at 2021 San Antonio Breast Cancer Symposium - Form 8-K
Encouraging Updated Data from Phase 2 MARIO-3 TNBC Trial Presented at 2021 San Antonio Breast Cancer Symposium - 88.6% of Evaluable 1L TNBC... | December 10, 2021
Source: marketscreener.com